Physician profile
Charles Shieh
NPI 1861651739
$18,907.23
in general payments reported to CMS, 2019-2025
15 companies · $4,915 in 2025
The $4,915 reported for 2025 was more than what 82% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2021: $2,311 · 2022: $8,716 · 2023: $167 · 2024: $1,373 · 2025: $4,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,073 · Travel and Lodging: $2,247 · Consulting Fee: $705 · Food and Beverage: $220 · Honoraria: $120 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,073.01 |
| Travel and Lodging | $2,247.04 |
| Consulting Fee | $705.00 |
| Food and Beverage | $219.52 |
| Honoraria | $120.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,693.83 | 2019-2025 | |
| Becton, Dickinson and Company | $940.00 | 2021-2023 | Bd Introsyte |
| Medtronic, INC. | $668.12 | 2021-2025 | Reliant |
| Astrazeneca Pharmaceuticals LP | $641.64 | 2019-2024 | Imfinzi |
| Medical Device Business Services, INC. | $279.34 | 2022 | |
| Merck Sharp & Dohme LLC | $217.33 | 2019 | |
| Ethicon INC. | $171.20 | 2021 | |
| W. L. Gore & Associates, INC. | $120.00 | 2024 | Gore Molding Occlusion Balloon Catheter |
| E.R. Squibb & Sons, L.L.C. | $44.67 | 2024 | Eliquis |
| Medtronic Vascular, INC. | $30.00 | 2019 | |
| Integra Lifesciences Corporation | $25.11 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Davol INC. | $24.27 | 2022 | |
| Ethicon US, LLC | $20.08 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.72 | 2023 | Libtayo |
| Janssen Pharmaceuticals, INC | $14.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Shieh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.